Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

SMAIO Provides Update on Its Partnership With NuVasive and Confirms Its Strategic Focus on the U.S. Market

Jan 27, 2025•over 1 year ago

Contract Type

partnership

Saint-PriestBiotechnologySoftwareHealth Care

Description

SMAIO provides an update regarding its partnership with NuVasive and confirms its strategic focus on development in the United States. The collaboration involves a development and license agreement to advance surgical planning solutions and commercialization efforts.

Company Information

Company

SMAIO

Location

Saint-Priest, Auvergne Rhône Alpes, France

About

SMAIO (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer founded in 2009 by a group of spine surgeons having extensive experience in spinal pathologies treatment and a particular focus on patient sagittal balance restoration. SMAIO aims to provide surgeons with integrated spinal solutions (software, implants, services, instruments, etc.).

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for SMAIO's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months